Most Recent
A unit of Johnson & Johnson has been ordered to pay around $40 million in legal costs to the lead applicants in a class action over pelvic mesh implants after a judge dismissed the company's bid to stay the costs until after a high profile appeal is heard next year.
The Insurance Council of Australia has asked the High Court to weigh in on its case against COVID-19 related claims in business interruption policies, following its high stakes loss in a ruling last month that found an infectious disease exclusion did not apply.
The ACCC has reached the end of the line in its challenge to Pacific National's $205 million acquisition of Aurizon's Acacia Ridge Terminal in Queensland, with the High Court dismissing the competition regulator's application to take up the appeal.
Apple wants to stay a competition lawsuit brought by video game developer Epic Games in Australia, claiming a clause in its developer contract requires any dispute between them to be heard in a California court.
A judge hearing Pfizer's application for preliminary discovery against Sandoz over its possible launch of an Enbrel biosimilar has found that such an application must be based on a current belief that the applicant could be entitled to relief.
Logistics services provider Qube has resolved a lawsuit that accused the Port of Newcastle of misusing its power in the market for port services by denying Qube's request to use its own equipment to provide dry bulk unloading services at the port.
A judge has vacated a seven-week trial in proceedings brought by ASIC against two former Rio Tinto executives to March or April 2022, after they requested a "lengthy delay" to ensure a COVID-19 vaccine would be available before they travel to Australia for trial.
Two companies owned by billionaire Clive Palmer have suffered a legal setback, with a judge setting aside prior orders enforcing two awards in a $30 billion mining dispute with the Western Australian government and criticising the companies for misleading the court.
A former Rio Tinto executive living in the US who wants to appear in person at an upcoming trial in a case brought by ASIC says the hearing should be moved to next year when a COVID-19 vaccine will likely become available and he could travel to Australia to "mount a vital defence".
The lead applicant in a class action against Bayer over allegedly defective Essure contraceptive devices will ask the court to discontinue its claims against two makers of the controversial medical implants.